2 terminated, 1 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 2, Completed 1 |
Follow GSK2647544: new trials by email Literature Review of GSK2647544 trials Research Report on GSK2647544
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers GSK2647544, drug-drug interaction - Alzheimer's Disease | Phase 1 | Terminated | GlaxoSmithKline | 12 | 2013-11-22 | 2017-06-08 |
| A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier. GSK2647544 oral, [18F]GSK2647544 IV bolus - Alzheimer's Disease | Phase 1 | Terminated | GlaxoSmithKline | 4 | 2013-08-19 | 2020-10-09 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers GSK2647544, Placebo - Alzheimer's Disease | Phase 1 | Completed | GlaxoSmithKline | 27 | 2012-10-19 | 2017-10-18 |
GlaxoSmithKline (3)
United Kingdom (2) · Australia (1)